Nutrition for children with cholestatic liver disease

E Leonie Los1, Sabina Lukovac, Anniek Werner

  • 1Pediatric Gastroenterology/Research Laboratory of Pediatrics, Department of Pediatrics, University Medical Center Groningen, University of Groningen, NL-9700 RB Groningen, The Netherlands.

Insights

Optimizing nutrition is vital for children with cholestatic liver disease (CLD) to improve growth and reduce mortality risk. Tailored nutritional strategies, informed by advanced nutrient metabolism studies, are crucial for these patients.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Nutritional Science
  • Biochemistry

Background:

  • Cholestatic liver disease (CLD) in children significantly impairs nutritional status, growth, and development, increasing morbidity and mortality risks.
  • Nutritional status is a key predictor of clinical outcomes in pediatric patients with CLD awaiting liver transplantation.
  • The heterogeneity of CLD necessitates individualized nutritional management strategies.

Purpose of the Study:

  • To highlight the critical role of nutritional status in pediatric cholestatic liver disease.
  • To review current understanding and future directions in assessing nutrient metabolism in CLD.
  • To emphasize the need for tailor-made nutritional therapies in children with CLD.

Main Methods:

  • Utilized stable isotope-labeled triglycerides and fatty acids in animal models and human studies to investigate fat absorption.
  • Reviewed existing literature on nutrient metabolism and absorption in pediatric CLD.
  • Discussed the potential application of isotope-labeled macronutrients (carbohydrates, proteins) for future assessments.

Main Results:

  • Stable isotope studies have elucidated fat absorption mechanisms in both physiological and cholestatic conditions.
  • Current understanding of carbohydrate and protein metabolism in pediatric CLD requires further investigation.
  • Nutritional status directly impacts the prognosis of children with CLD.

Conclusions:

  • Optimizing nutritional status is essential for improving outcomes in children with CLD.
  • Further research using stable isotopes for carbohydrates and proteins will enable more precise nutritional assessments.
  • Development of personalized nutritional therapies is paramount for managing pediatric CLD effectively.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...